Participants 105 142 4
polycystic ovarian syndrome patients.
Participants 339 383 3
polycystic ovarian syndrome (PCOS) patients.
Participants 435 524 3
patients with PCOS undergoing controlled ovarian hyperstimulation (COH) with GnRH agonist
Participants 592 784 7
METHODS The present clinical trial compared GnRH antagonist (cetrorelix) and GnRH agonist (buserelin) protocols during COH of 112 infertile PCOS patients entering assisted reproduction cycles.
